Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.3928.99-10.0912.99274.74

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is -5.39 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.39
Mar202428.99
Mar2023-10.09
Mar202212.99
Mar2021274.74

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.39
Negative
Mar2024 28.99
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹138.8 Cr 1.4% 13.4% -11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -0.7% -3.6% 6% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr 1.1% -1.2% -0.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr 1.6% 1.4% 36.7% Stock Analytics
CIPLA ₹113,155.0 Cr 0.7% 2.6% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,652.0 Cr -0.9% -2.5% 1.2% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

1.4%

13.4%

-11.4%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses